Jarden analysts are pondering the impact of Medicare contractor Novitas not covering Pacific Edge’s Cxbladder in its local cover determination, while the healthcare company’s shares are in a trading halt pending a material announcement
Analyst
Jarden analysts are pondering the impact of Medicare contractor Novitas not covering Pacific Edge’s Cxbladder in its local cover determination, while the healthcare company’s shares are in a trading halt pending a material announcement
Analyst
'Leveraging our innovative reputation in the pursuit of creating remarkable homes'.